Skip to content
Allegiance Pharmaceutical
Log in Cart

Dosoquin with MenaQ7 Education

Dosoquin with MenaQ7

Videos

Vitamin K2 and Cardiovascular Calcification

Vitamin K2 and Bone Metabolism

Studies

Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women

Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women: double-blind randomised clinical trial

Proper Calcium Use: Vitamin K2 as a Promoter of Bone and Cardiovascular Health

Vitamin K2 MK-7: prevention and treatment of arterial calcification

Vitamin K and the Prevention of Fractures

Matrix Gla-protein: The calcification inhibitor in need of vitamin K

The risk of nephrolithiasis is causally related to inactive matrix Gla protein, a marker of vitamin K status: a Mendelian randomization study in a Flemish population

About

  • Who We Are
  • General Questions
  • Contact Us

Legal

  • Terms of Use
  • Privacy Policy

Join our mailing list


* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
© 2023, Allegiance Pharmaceutical
© 2023, Allegiance Pharmaceutical
Use left/right arrows to navigate the slideshow or swipe left/right if using a mobile device
  • choosing a selection results in a full page refresh